ArticleBlood cancer journal2026
Single agent selinexor is active in patients with myelofibrosis refractory or intolerant to JAK inhibitors.
Srinivas K Tantravahi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it